SAS in Patients With Bronchial Carcinoma
SAS CA
Incidence of Sleep Apnea Syndrome (SAS) in Patients With Bronchial Carcinoma
1 other identifier
interventional
100
1 country
3
Brief Summary
In this study it will be analyzed how often the sleep apnea syndrome can be observed in patients with newly diagnosed lung cancer with the help of ApneaLink device by ResMed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2014
Typical duration for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2014
CompletedFirst Submitted
Initial submission to the registry
October 14, 2014
CompletedFirst Posted
Study publicly available on registry
October 21, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2016
CompletedFebruary 18, 2016
February 1, 2016
2.7 years
October 14, 2014
February 17, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
percent of sleep apnea in patients with bronchial carcinoma
The percent of sleep apnea in a cohort of patients with bronchial carcinoma will be evaluated. The duration of the study participation is two days.
two days
Study Arms (1)
sleep apnea screening with ApneaLinkTM
OTHERThis is the only group in the present study. Patients with bronchial carcinoma (or reasonable suspicion) perform sleep screening with ApneaLinkTM at home or during the hospitalization.
Interventions
ApneaLink is sleep-screening tool that objectively identifies patients with sleep apnea
Eligibility Criteria
You may qualify if:
- Patients with reasonable suspicion of bronchial carcinoma or histologically proven bronchial carcinoma, which has not been medicated until the study entry and
- Patients with sleep apnea who had recently been diagnosed with bronchial carcinoma.
You may not qualify if:
- Pregnancy
- other already known malignancies or tumors
- Patients with non-invasive artificial respiration due to a chronic respiratory insufficiencies
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Medizinische Klinik I Uniklinik RWTH Aachen
Aachen, North Rhine-Westphalia, 52074, Germany
Krankenhaus Merheim
Cologne, North Rhine-Westphalia, 51109, Germany
Florence-Nightingale Hospital
Düsseldorf, 40489, Germany
Related Publications (1)
Dreher M, Kruger S, Schulze-Olden S, Keszei A, Storre JH, Woehrle H, Arzt M, Muller T. Sleep-disordered breathing in patients with newly diagnosed lung cancer. BMC Pulm Med. 2018 May 16;18(1):72. doi: 10.1186/s12890-018-0645-1.
PMID: 29769049DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michael Dreher, Univ.-Prof.
RWTH Aachen University Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 14, 2014
First Posted
October 21, 2014
Study Start
April 1, 2014
Primary Completion
December 1, 2016
Study Completion
December 1, 2016
Last Updated
February 18, 2016
Record last verified: 2016-02